{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T21:12:06Z","timestamp":1765228326585,"version":"3.46.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Childhood tuberculosis (TB) remains under-reported and undiagnosed. A full complement of diagnostic tests is oftentimes unavailable in resource limited country like Ethiopia. This study assesses the contribution of Xpert MTB\/RIF assay and urine LF-LAM for childhood TB diagnosis using sputum and urine samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A facility based cross-sectional study was conducted in children between 5 and 14 years of age. Sputum and urine samples were collected from children with presumptive TB. The samples were tested for TB using LF-LAM, Xpert MTB\/RIF assay, concentrated smear microscopy, and culture. Diagnostic performance of Xpert MTB\/RIF assay was analyzed and compared against culture, which was used as the gold standard. Urine LF-LAM test result was compared to a composite reference standard.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Of 576 participants with presumptive TB enrolled in the study, 519 (90.1%) had complete clinical data and bacteriological laboratory test results. Active TB was diagnosed in 14.1% (73\/519), and bacteriological confirmation was made in 10.1% (52\/515) of children with presumptive TB. The odds of being diagnosed with a bacteriologically confirmed TB are significantly higher in children who have household contact history with TB patient (aOR 2.27, P\u2009=\u20090.03) and age above 10 years (aOR 3.67, P\u2009&lt;\u20090.001). Xpert MTB\/RIF test had sensitivity of 79% using culture as the gold standard. Compared to smear microscopy, the sensitivity of the Xpert MTB\/RIF assay increased by 50% for children aged 5\u20139 years and by 40% for children and adolescents living with HIV (C\/ALHIV). All bacteriologically confirmed (n\u2009=\u20092) and clinically diagnosed TB children (n\u2009=\u20092) who live with HIV were tested positive for urine LF-LAM. The overall sensitivity of urine LF-LAM was 27.6% when using the composite reference standard, compared to 17.9% when the bacteriological reference standard was applied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pulmonary TB diagnosis was greatly improved with the use of Xpert MTB\/RIF assay, particularly in children aged 5\u20139 years and C\/ALHIV who typically have difficulty producing good quality sputum. Urine LF-LAM performed well in children\/adolescents who tested positive for HIV, but it performed poorly in the other variables, which suggests that urine LF-LAM testing did not play a critical role in TB diagnosis in children with negative HIV status.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0338557","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T18:29:38Z","timestamp":1765218578000},"page":"e0338557","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Contribution of xpert MTB\/RIF assay and Urine LF-LAM for the diagnosis of tuberculosis in children aged 5 \u2013 14 years, at selected health facilities in Ethiopia, 2016 \u2013 2019"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3407-983X","authenticated-orcid":true,"given":"Muluwork","family":"Getahun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yenew","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilina","family":"Molalegn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayinalem","family":"Alemu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Getu","family":"Diriba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waganeh","family":"Sinshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengistu","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ephrem","family":"Tesfaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kassahun","family":"Belachew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameha","family":"Mekasha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beniam","family":"Feleke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"pone.0338557.ref001","volume-title":"Global tuberculosis report","author":"World Health Organization","year":"2022"},{"key":"pone.0338557.ref002","volume-title":"Roadmap towards ending TB in children and adolescents","author":"World Health Organization","year":"2018"},{"key":"pone.0338557.ref003","volume-title":"Tuberculosis, Leprosy, and Other Lung Diseases National Strategic Plan","author":"Federal ministry of health of Ethiopia","year":"2023"},{"issue":"5","key":"pone.0338557.ref004","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S2352-4642(23)00004-4","article-title":"Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis","volume":"7","author":"KS Gunasekera","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"pone.0338557.ref005","article-title":"Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel","author":"SM Graham","year":"2012","journal-title":"J Infect Dis"},{"key":"pone.0338557.ref006","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jir879","article-title":"Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel","volume":"205","author":"LE Cuevas","year":"2012","journal-title":"J Infect Dis"},{"key":"pone.0338557.ref007","volume-title":"Xpert MTB\/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children","author":"WP Update","year":"2013"},{"key":"pone.0338557.ref008","volume-title":"Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV: policy update (2019): evidence to decision tables. WHO\/CDS\/TB\/2019.21","author":"World Health Organization","year":"2019"},{"key":"pone.0338557.ref009","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/1471-2334-13-407","article-title":"Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies","volume":"13","author":"SD Lawn","year":"2013","journal-title":"BMC Infect Dis"},{"key":"pone.0338557.ref010","volume-title":"WHO consolidated guidelines on tuberculosis. Module 5: management of tuberculosis in children and adolescents","author":"World Health Organization","year":"2022"},{"key":"pone.0338557.ref011","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fped.2019.00034","article-title":"Xpert MTB\/RIF ultra for tuberculosis testing in children: A mini-review and commentary","volume":"7","author":"RR Atherton","year":"2019","journal-title":"Front Pediatr"},{"issue":"1","key":"pone.0338557.ref012","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5588\/ijtld.22.0372","article-title":"Isolation and purification of lipoarabinomannan from urine of adults with active TB","volume":"27","author":"JL Cantera","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"pone.0338557.ref013","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12879-023-08216-w","article-title":"HIV matters when diagnosing TB in young children: an ancillary analysis in children enrolled in the INPUT stepped wedge cluster randomized study","volume":"23","author":"L Powell","year":"2023","journal-title":"BMC Infect Dis"},{"key":"pone.0338557.ref014","volume-title":"The Union\u2019s desk guide for diagnosis and management of TB in children","author":"Union IU against T and LD","year":"2016"},{"key":"pone.0338557.ref015","volume-title":"WHO consolidated guidelines on tuberculosis: Module 1: Prevention-infection prevention and control","author":"World Health Organization","year":"2022"},{"key":"pone.0338557.ref016","unstructured":"The Alere Determine TB LAM Ag. [Cited 2023 August 9]. https:\/\/www.ultralabealtd.co.ke\/downloads\/alere\/TB-LAM-Ag-Brochure.pdf"},{"key":"pone.0338557.ref017","volume-title":"Xpert MTB\/RIF implementation manual: technical and operational \u2018how-to\u2019; practical considerations. WHO\/HTM\/TB\/2014.1","author":"World Health Organization","year":"2014"},{"key":"pone.0338557.ref018","volume-title":"Mycobacteriology laboratory manual","author":"Global Laboratory Initiative STP","year":"2014"},{"issue":"4","key":"pone.0338557.ref019","article-title":"Rapid immunochromatographic test for the identification and discrimination of mycobacterium tuberculosis complex isolates from non-tuberculous mycobacteria","volume":"8","author":"VP Shenoy","year":"2014","journal-title":"J Clin Diagn Res"},{"issue":"11","key":"pone.0338557.ref020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207552","article-title":"Seasonal patterns of tuberculosis case notification in the tropics of Africa: A six-year trend analysis in Ethiopia","volume":"13","author":"Z Gashu","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"pone.0338557.ref021","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4269\/ajtmh.19-0816","article-title":"Factors determining treatment success in children with drug-sensitive tuberculosis in Ethiopia: A three-year retrospective analysis","volume":"103","author":"D Habte","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"pone.0338557.ref022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241977","article-title":"Evaluating the integration of tuberculosis screening and contact investigation in tuberculosis clinics in Ethiopia: A mixed method study","volume":"15","author":"L Ketema","year":"2020","journal-title":"PLoS One"},{"key":"pone.0338557.ref023","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.2147\/IDR.S433789","article-title":"Pulmonary tuberculosis and rifampicin resistant mycobacterium tuberculosis in children and adolescents using gene xpert MTB\/RIF assay in tigray, Northern Ethiopia","volume":"16","author":"TA Dejene","year":"2023","journal-title":"Infect Drug Resist"},{"issue":"03","key":"pone.0338557.ref024","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4236\/jtr.2018.63020","article-title":"Increasing detection and confirmation of tuberculosis in children in Southern Ethiopia: Pooled samples tested using microscopy and xpert","volume":"06","author":"DG Datiko","year":"2018","journal-title":"JTR"},{"key":"pone.0338557.ref025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijregi.2022.04.008","article-title":"Magnitude of tuberculosis and its associated factors among under-five children admitted with severe acute malnutrition to public hospitals in the city of Dire Dawa, Eastern Ethiopia, 2021: multi-center cross-sectional study","volume":"3","author":"KA Atalell","year":"2022","journal-title":"IJID Reg"},{"issue":"1","key":"pone.0338557.ref026","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1186\/s12889-019-7597-0","article-title":"Contact screening and risk factors for TB among the household contact of children with active TB: a way to find source case and new TB cases","volume":"19","author":"M Laghari","year":"2019","journal-title":"BMC Public Health"},{"issue":"9","key":"pone.0338557.ref027","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.5588\/ijtld.16.0471","article-title":"A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia","volume":"21","author":"DG Datiko","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"pone.0338557.ref028","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jinf.2018.07.002","article-title":"Xpert MTB\/RIF ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study","volume":"77","author":"I Sabi","year":"2018","journal-title":"J Infect"},{"issue":"18","key":"pone.0338557.ref029","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1056\/NEJMoa1303657","article-title":"Diagnosis of childhood tuberculosis and host RNA expression in Africa","volume":"370","author":"ST Anderson","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0338557.ref030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10096-021-04340-0","article-title":"Detection of pulmonary tuberculosis in children using the Xpert MTB\/RIF ultra assay on sputum: a multicenter study","volume":"41","author":"X Peng","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"pone.0338557.ref031","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.5588\/ijtld.20.0391","article-title":"Childhood TB in China: notification, characteristics and risk factors for outcomes, 2010-2017","volume":"24","author":"T Li","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"pone.0338557.ref032","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/ijmy.ijmy_1_23","article-title":"Trends in pediatric tuberculosis diagnosis utilizing xpert Mycobacterium tuberculosis\/Rifampicin in a poor-resource, high-burden region: A retrospective, multicenter study","volume":"12","author":"MA Garba","year":"2023","journal-title":"The International Journal of Mycobacteriology"},{"issue":"9","key":"pone.0338557.ref033","article-title":"Evaluation of xpert MTB\/RIF ultra assay for diagnosis of childhood tuberculosis: a multicenter accuracy study","volume":"58","author":"L Sun","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"1","key":"pone.0338557.ref034","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/tropej\/fmy005","article-title":"Evaluation of xpert MTB\/RIF assay for diagnosis of tuberculosis in children","volume":"65","author":"A Das","year":"2019","journal-title":"J Trop Pediatr"},{"issue":"8","key":"pone.0338557.ref035","article-title":"Xpert MTB\/RIF and Xpert MTB\/RIF Ultra assays for active tuberculosis and rifampicin resistance in children","volume":"8","author":"AW Kay","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"pone.0338557.ref036","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5588\/ijtld.21.0195","article-title":"TB testing in HIV-positive patients prior to antiretroviral treatment","volume":"26","author":"E Spooner","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0338557.ref037","article-title":"Diagnosing TB in those hardest to diagnose: urine lipoarabinomannan for suspects of disseminated and extrapulmonary TB","volume-title":"In Abstract of the 20th Conference on Retroviruses and Opportunistic Infections (CROI)","author":"A Van Rie","year":"2013"},{"key":"pone.0338557.ref038","author":"M Shah","year":"2013","journal-title":"Comparative performance of rapid urinary lipoarabinomannan assays and xpert MTB\/RIF in HIV-positive TB suspects: Uganda. In: Atlanta, USA"},{"issue":"3","key":"pone.0338557.ref039","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1183\/09031936.00003315","article-title":"Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania","volume":"46","author":"I Kroidl","year":"2015","journal-title":"Eur Respir J"},{"issue":"6","key":"pone.0338557.ref040","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1183\/09031936.00025711","article-title":"Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis","volume":"38","author":"J Minion","year":"2011","journal-title":"Eur Respir J"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0338557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T18:29:46Z","timestamp":1765218586000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0338557"}},"subtitle":[],"editor":[{"given":"Novel Njweipi","family":"Chegou","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0338557","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]}}}